JOHNSON & JOHNSON

JOHNSON & JOHNSON held its 2026 Annual Meeting of Shareholders on April 23, 2026. Shareholders elected all 12 director nominees, approved the executive compensation on an advisory basis, and ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. Additionally, a shareholder proposal to adopt a policy requiring an independent board chair was not approved.

Johnson & Johnson submitted its Quarterly Report on Form 10-Q for the fiscal quarter ended March 29, 2026. The filing confirms the company's status as a large accelerated filer and includes its consolidated financial statements. As of April 17, 2026, the company reported 2,407,216,971 shares of common stock outstanding.

Johnson & Johnson announced a 3.1% increase in its quarterly dividend, raising it from $1.30 to $1.34 per share. This marks the 64th consecutive year of dividend increases for the company, demonstrating a consistent return to shareholders. The new annual dividend rate will be $5.36 per share, payable on June 9, 2026, to shareholders of record on May 26, 2026. The company also announced its first-quarter 2026 sales and earnings.

Johnson & Johnson announced a 3.1% increase in its quarterly dividend, raising it from $1.30 to $1.34 per share. This marks the 64th consecutive year the company has increased its dividend, reflecting a strong commitment to shareholder returns. The new annual dividend rate will be $5.36 per share, payable on June 9, 2026, to shareholders of record as of May 26, 2026. The company also announced its first-quarter 2026 sales and earnings.

Johnson & Johnson filed an 8-K announcing its sales and earnings for the fourth quarter and full year ended December 28, 2025. This provides investors with insight into the company's recent financial performance and overall health.

Johnson & Johnson's definitive proxy statement announces the upcoming virtual annual meeting where shareholders will vote on key proposals, including the election of 12 director nominees, advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as the independent auditor, and a shareholder proposal. The meeting provides shareholders an opportunity to participate in corporate governance and influence company direction.